Pharma News

Keep updating your pharma knowledge
20 Sep 2016

Zydus partners Takeda to develop, market vaccine for chikungunya

Posted By

Zydus Cadila has partnered with Japanese drug maker Takeda Pharmaceutical Co. Ltd to develop and commercialise a vaccine against chikungunya.

The broad-based agreement includes early-stage development to the final commercialisation of the vaccine.

The financial terms of the agreement were not disclosed.

Leave a Reply

The reCAPTCHA verification period has expired. Please reload the page.

Upskill Your Pharma Knowledge

Explore Next Gen Learning

Case Studies & Caselets | Simulation Based Learning | E-Lectures | Online Self Competency Assessments

Thank You for Subscription!